MA52629A - Agents inhibiteurs de la tyrosine kinase de bruton - Google Patents
Agents inhibiteurs de la tyrosine kinase de brutonInfo
- Publication number
- MA52629A MA52629A MA052629A MA52629A MA52629A MA 52629 A MA52629 A MA 52629A MA 052629 A MA052629 A MA 052629A MA 52629 A MA52629 A MA 52629A MA 52629 A MA52629 A MA 52629A
- Authority
- MA
- Morocco
- Prior art keywords
- tyrosine kinase
- kinase inhibitors
- bruton tyrosine
- bruton
- inhibitors
- Prior art date
Links
- 102000001714 Agammaglobulinaemia Tyrosine Kinase Human genes 0.000 title 1
- 108010029445 Agammaglobulinaemia Tyrosine Kinase Proteins 0.000 title 1
- 229940121358 tyrosine kinase inhibitor Drugs 0.000 title 1
- 239000005483 tyrosine kinase inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862671053P | 2018-05-14 | 2018-05-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA52629A true MA52629A (fr) | 2021-03-24 |
Family
ID=67002348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA052629A MA52629A (fr) | 2018-05-14 | 2019-05-13 | Agents inhibiteurs de la tyrosine kinase de bruton |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US10899753B2 (fr) |
| EP (1) | EP3793994B1 (fr) |
| JP (1) | JP7359782B2 (fr) |
| AR (1) | AR115085A1 (fr) |
| ES (1) | ES2968222T3 (fr) |
| MA (1) | MA52629A (fr) |
| TW (1) | TW202016097A (fr) |
| UY (1) | UY38233A (fr) |
| WO (1) | WO2019222101A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA53914A (fr) * | 2018-10-15 | 2021-08-25 | Biogen Ma Inc | Polymorphes cristallins d'inhibiteurs de la tyrosine kinase de bruton |
| CN110627775B (zh) * | 2019-10-24 | 2026-01-30 | 特科罗生物科技(成都)有限公司 | 一种小分子化合物 |
| JP7646671B2 (ja) * | 2019-12-23 | 2025-03-17 | バイオジェン・エムエイ・インコーポレイテッド | Ｂｔｋ阻害剤 |
| CN112062691B (zh) * | 2020-06-18 | 2022-12-09 | 中国农业科学院油料作物研究所 | 一种柠檬醛苯丁酸肟酯类化合物及其合成方法和应用 |
| WO2022212893A1 (fr) | 2021-04-02 | 2022-10-06 | Biogen Ma Inc. | Méthodes de traitement combiné de la sclérose en plaques |
| MX2024008060A (es) | 2021-12-30 | 2024-07-10 | Beigene Switzerland Gmbh | Degradacion de la tirosina quinasa de bruton (btk) mediante conjugacion de inhibidores de la btk con ligando de ligasa e3 y metodos de uso. |
| JP7805983B2 (ja) | 2022-03-22 | 2026-01-26 | アッヴィ・インコーポレイテッド | ブルトン型チロシンキナーゼを分解するためのピリミジン |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4938949A (en) | 1988-09-12 | 1990-07-03 | University Of New York | Treatment of damaged bone marrow and dosage units therefor |
| CN104169260A (zh) * | 2012-03-09 | 2014-11-26 | 卡尔那生物科学株式会社 | 新三嗪衍生物 |
| US10280169B2 (en) | 2013-12-11 | 2019-05-07 | Biogen Ma Inc. | Biaryl bruton's tyrosine kinase inhibitors |
| HRP20181109T1 (hr) | 2013-12-11 | 2018-11-02 | Biogen Ma Inc. | Spojevi biarila korisni za liječenje ljudskih bolesti u onkologiji, neurologiji i imunologiji |
| WO2016201280A1 (fr) * | 2015-06-10 | 2016-12-15 | Biogen Ma Inc. | Formes et compositions d'inhibiteurs biaryles de la tyrosine kinase de bruton |
-
2019
- 2019-05-13 EP EP19732766.1A patent/EP3793994B1/fr active Active
- 2019-05-13 TW TW108116422A patent/TW202016097A/zh unknown
- 2019-05-13 ES ES19732766T patent/ES2968222T3/es active Active
- 2019-05-13 UY UY0001038233A patent/UY38233A/es not_active Application Discontinuation
- 2019-05-13 WO PCT/US2019/032018 patent/WO2019222101A1/fr not_active Ceased
- 2019-05-13 JP JP2020564219A patent/JP7359782B2/ja active Active
- 2019-05-13 MA MA052629A patent/MA52629A/fr unknown
- 2019-05-13 AR ARP190101270A patent/AR115085A1/es unknown
- 2019-05-13 US US16/410,725 patent/US10899753B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20190382394A1 (en) | 2019-12-19 |
| TW202016097A (zh) | 2020-05-01 |
| JP7359782B2 (ja) | 2023-10-11 |
| EP3793994B1 (fr) | 2023-08-23 |
| EP3793994A1 (fr) | 2021-03-24 |
| ES2968222T3 (es) | 2024-05-08 |
| US10899753B2 (en) | 2021-01-26 |
| WO2019222101A1 (fr) | 2019-11-21 |
| UY38233A (es) | 2019-12-31 |
| JP2021523206A (ja) | 2021-09-02 |
| AR115085A1 (es) | 2020-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3873477A4 (fr) | Inhibiteurs de la kinase cycline-dépendante 7 (cdk7) | |
| MA53921A (fr) | Inhibiteurs de protéine tyrosine phosphatase | |
| IL286462A (en) | Protein tyrosine phosphatase inhibitors | |
| EP3844151A4 (fr) | Inhibiteurs de kras g12c | |
| MA54543A (fr) | Inhibiteurs de kif18a | |
| MA54550A (fr) | Inhibiteurs de kif18a | |
| MA42623A (fr) | Inhibiteurs de la tyrosine kinase de bruton | |
| EP3414234A4 (fr) | Inhibiteurs de la tyrosine kinase de bruton | |
| EP3710439A4 (fr) | Inhibiteurs de kras g12c | |
| MA43162A (fr) | Inhibiteurs de type imidazopyrazine de tyrosine kinase de bruton | |
| EP3405192A4 (fr) | Inhibiteurs de la tyrosine kinase de bruton | |
| EP3740206A4 (fr) | Inhibiteurs de la kinase cycline-dépendante 7 (cdk7) | |
| MA52812A (fr) | Inhibiteurs de sarm1 | |
| MA42242A (fr) | Inhibiteurs de la tyrosine kinase | |
| MA52813A (fr) | Inhibiteurs de sarm1 | |
| MA41350A (fr) | Synthèse d'un inhibiteur de la tyrosine kinase de bruton | |
| EP3902805A4 (fr) | Inhibiteurs de kinase cycline-dépendants | |
| MA52809A (fr) | Inhibiteurs de sarm1 | |
| EP3804707A4 (fr) | Inhibiteur de kinase | |
| EP3817736A4 (fr) | Inhibiteurs de pikfyve | |
| EP3962908A4 (fr) | Inhibiteurs hétérocycliques de tyrosine kinase | |
| DK3609886T3 (da) | Benzoazepinanaloger som inhiberingsmidler for bruton-tyrosinkinase | |
| MA41827A (fr) | Formes solvatées d'un inhibiteur de la tyrosine kinase de bruton | |
| ZA201906887B (en) | Bruton's tyrosine kinase inhibitors | |
| MA42510A (fr) | Formes et compositions d'inhibiteurs biaryles de la tyrosine kinase de bruton |